이지바이오

이지바이오 ("EASY BIO") is an active South Korean mid-sized enterprise specializing primarily in the manufacture of compound feeds and feed additives for livestock, with core expertise rooted in fermentation engineering, enzyme technology, and agricultural biotechnology applications. It was established as an independent entity following a split from its parent holding group "이지홀딩스" around May–June 2020. The company's main business lines are piglet feeds ("자돈사료") and functional nutritional supplements/additives for animals—not drugs or therapies intended for humans. It operates globally through subsidiaries such as EASY BIO USA INC and has recently merged operations with Devenish Nutrition LLC to expand its international footprint. While it leverages biotechnological processes within agriculture—such as fermentation—it does not operate within the pharmaceutical/life sciences sector targeting human health nor maintain any clinical-stage drug development programs. The firm is publicly traded on KOSDAQ under symbol A353810, employs approximately 115–171 people, reports annual revenues exceeding $100 million USD, and maintains headquarters at Gangnam-daero, Seoul.